Table of Contents
Editorial
| Why Open Medicine? | HTML PDF |
| James Maskalyk, for the Editors of Open Medicine | 1-2 |
Research
| Factors related to use of prostate cancer screening: The Alberta Tomorrow Project | HTML PDF |
| Harriet Richardson, Kristan J Aronson, Alison James, Elizabeth S McGregor, Heather Bryant | 3-12 |
| Rural medical students at urban medical schools: Too few and far between? | HTML PDF |
| Jennifer M Hensel, Maureen Shandling, Donald Redelmeier | 13-17 |
| Accuracy of administrative databases in identifying patients with hypertension | HTML PDF |
| Karen Tu, Norman RC Campbell, Xhong-Liang Chen, Karen J Cauch-Dudek, Finlay A McAlister | 18-26 |
Review
| A systematic review of studies comparing health outcomes in Canada and the United States | HTML PDF |
| Gordon Guyatt, PJ Devereaux, Joel Lexchin, Samuel B Stone, Armine Yalnizyan, David Himmelstein, Steffie Woolhandler, Qi Zhou, Laurie Goldsmith, Deborah J Cook, Ted Haines, Christina Lacchetti, John Lavis, Terrence Sullivan, Ed Mills, Shelley Kraus, Neera Bhatnagar | 27-36 |
Analysis and Comment
| Direct-to-consumer advertising and expenditure on prescription drugs: A comparison of experiences in the United States and Canada | HTML PDF |
| Steven G Morgan | 37-45 |
| The joys and challenges of being an open access medical journal | HTML PDF |
| Gavin Yamey, Virginia Barbour, Barbara Cohen, Larry Peiperl, Paul Chinnock | 46-48 |
| Peer review in open access scientific journals | HTML PDF |
| Matthew E Falagas | 49-51 |
| The media–medicine mix: quality concerns in medical reporting | HTML PDF |
| Alan KE Cassels | 52-54 |
Clinical Practice
| Decision-making in primary care: Does screening for peripheral arterial disease improve risk stratification for patients at intermediate coronary risk? | HTML PDF |
| Michelle Greiver | 55-57 |
Colloquium
| Pharmaceutical ethics? | HTML PDF |
| Jerome P Kassirer | 58-59 |
Letters
| Some problems adressing medical publishing and - maybe - Open Medicine | |
| Manfred Gogol |
ISSN 1911-2092